Dermatology

A Wealth of Experience

We have collaborated with our clients on projects to research cutaneous diseases, cutaneous treatment, and complications and comorbidities of cutaneous disease.  Our experience includes:  

  • Acne
  • Alopecia
  • Atopic dermatitis
  • Dry skin
  • Eczema
  • Herpes
  • Psoriasis
  • Skin cancer
    • Basal cell carcinoma
    • Squamous cell carcinoma
    • Melanoma
  • Stevens-Johnson syndrome
  • Systemic lupus erythematosus
  • Toxic epidermal necrolysis
  • Warts

Types of Projects

We have implemented studies to help our clients develop strategies in the dermatology market and to develop and gain 
market access for products to treat cutaneous diseases and complications arising from treatment of cutaneous illnesses. 

Recent projects have included:

Our Experts

Dawn Odom
Vice President, Biostatistics
Chris Knight
Senior Director, Health Economics
Dee Dee Mladsi (she/her)
Head, Health Economics—Strategy and Early Modeling
Diane Whalley
Executive Director, Patient-Centered Outcomes Assessment
Bintu Sherif
Director, Biostatistics
Mary Anthony
Senior Director, Epidemiology
Anita Brogan
Head, Decision Analytic Modeling, Health Economics
Xiaolei Zhou
Director, Biostatistics
Katherine Stull
Director, Health Economics
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Marci Clark
Director, Patient-Centered Outcomes Assessment
Maria Fernandez
Senior Director, Market Access and Outcomes Strategy
Patricia Sacco
Executive Director, Surveys and Observational Studies
Dana DiBenedetti
Executive Director, Patient-Centered Outcomes Assessment
Elena Rivero
Senior Director, Epidemiology
Ari Gnanasakthy
Principal Scientist, Patient-Centered Outcomes Assessment
Daniel Mines
Senior Director, Epidemiology
Lori McLeod
Vice President, Patient-Centered Outcomes Assessment
Anne Heyes
Vice President, Head Market Access and Outcomes Strategy, Europe
Jessica Costello
Senior Associate, Market Access and Outcomes Strategy
Josephine Mauskopf
Vice President, Health Economics
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Lauren Nelson
Executive Director, Psychometrics, Patient-Centered Outcomes Assessment
T. Michelle Brown
Senior Director, Patient-Centered Outcomes Assessment
Sorrel Wolowacz
Head, European Health Economics
Caroline Ling
Executive Director and HTA Specialist, Market Access and Outcomes Strategy
Jin Yang
Associate Director, Market Access and Outcomes Strategy
William L Herring
Senior Director, Health Economics
Sheri Fehnel
Vice President, Patient-Centered Outcomes Assessment
Kelly Hollis
Vice President, Surveys and Observational Studies
Mark Price
Senior Director, Health Economics
James Twiss
Director, Patient-Centered Outcomes Assessment
Margaret Mordin
Executive Director, Market Access and Outcomes Strategy

Selected Recent Dermatology Publications

Arana A, Pottegard A, Kuiper JG, Crellin E, Reutfors J, Schmitt-Egenolf M, Lund LC, Houben E, Booth H, Calingaert B, Kaye JA, Gembert K, Rothman KJ, Dedman D, Kieler H, Gutierrez L, Hallas J, Perez-Gutthann S. To what extent are topical tacrolimus or pimecrolimus associated with an increased risk of skin cancer and lymphoma? Long-term results from JOELLE study. Poster presented at the 2020 Virtual European Academy of Dermatology and Venereology Conference; October 29, 2020. Previously presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management.